Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Health Aff (Millwood). 2020 Feb;39(2):214–223. doi: 10.1377/hlthaff.2019.00687

Health Care Spending And Use Among People Experiencing Unstable Housing In The Era Of Accountable Care Organizations

Katherine A Koh 1, Melanie Racine 1, Jessie M Gaeta 1, John Goldie 1, Daniel P Martin 1, Barry Bock 1, Mary Takach 1, James J O’Connell 1, Zirui Song 1
PMCID: PMC7384249  NIHMSID: NIHMS1608999  PMID: 32011951

Abstract

Provider organizations are increasingly held accountable for health care spending in vulnerable populations. Longitudinal data on health care spending and use among people experiencing episodes of homelessness could inform the design of alternative payment models. We used Medicaid claims data to analyze spending and use among 402 people who were continuously enrolled in the Boston Health Care for the Homeless Program (BHCHP) from 2013 through 2015, compared to spending and use among 18,638 people who were continuously enrolled in Massachusetts Medicaid with no evidence of experiencing homelessness. The BHCHP population averaged $18,764 per person per year in spending—2.5 times more than spending among the comparison Medicaid population ($7,561). In unadjusted analyses this difference was explained by greater spending in the BHCHP population on outpatient care, including emergency department care, as well as on inpatient care and prescription drugs. After adjustment for covariates and multiple hypothesis testing, the difference was largely driven by outpatient spending. Differences were sensitive to adjustments for risk score, which suggests that housing instability and health risk are meaningfully correlated. This longitudinal analysis improves understanding of health care use and resource needs among people who are homeless or have unstable housing, and it could inform the design of alternative payment models for vulnerable populations.


Housing is a social determinant of health.1 However, efforts to describe the relationship between unstable housing and health care spending and use have been limited by the lack of reliable data. In an era in which health care provider organizations are increasingly taking financial responsibility for population health and spending, understanding the contributions of social determinants such as unstable housing is essential. This understanding could inform the design of new population-based payment models that aim to support the delivery of high-quality care for vulnerable populations, maintain financial viability for providers, and achieve cost savings for public programs.2

A prominent example of these alternative payment models, the accountable care organization (ACO) contracting model, is increasingly prevalent among providers that serve disadvantaged and low-income populations. This model of care has the potential to benefit vulnerable populations through improved access to primary care for patients who often use acute services, financial flexibility for behavioral health integration for patients with a high burden of mental health need, and risk-adjusted payments for their providers. However, without adequate adjustment that takes into account social determinants of health such as housing, population-based payment models might not sufficiently finance providers for the health care of people they serve.

In 2018 the Massachusetts Medicaid program launched an ACO model across seventeen provider organizations in the state, some of whose attributed patients included homeless people.3 As of February 2018 twelve states had Medicaid ACO programs, and at least ten more were pursuing them.4 Thus, Massachusetts is an early model that may provide useful lessons for other states. To date, there has been a dearth of longitudinal research on important subpopulations—such as people experiencing unstable housing—that can provide valuable insights to inform Medicaid ACO programs.

Previous studies have noted a high rate of health care use, particularly emergency department and inpatient visits, among the homeless population in the US—even those who are insured.517 However, while providing valuable groundwork, the literature has been largely cross-sectional,516 based on self-reported data on health care use,8,9,11,1316 and not comprehensive.814 Moreover, many of these studies focused on care delivered at a single clinical site or practice.10,14,15,17 Many lacked a comparison group,5,9,10,13,15 and few had data on health care spending in addition to use.5,79,1117 Finally, most of these studies were based on data from the period before the Affordable Care Act, when ACO contracts were less prevalent.57,916

This study examined Medicaid claims data across three years in a continuously enrolled population cared for by the Boston Health Care for the Homeless Program (BHCHP) in the Massachusetts Medicaid Primary Care Payment Reform Initiative (a value-based payment program that was a precursor to the state’s Medicaid ACO program). We analyzed medical and pharmaceutical spending and use in the period 2013–15 and compared spending and use in the BHCHP population to those in a continuously enrolled Massachusetts Medicaid population with no evidence of experiencing homelessness in their health care records. In addition, we compared the prevalence of clinical diagnoses in the two populations.

STUDY DATA AND METHODS

STUDY POPULATION

The BHCHP is one of the largest freestanding homeless health care programs in the US, serving 11,000 people across forty-five clinical sites throughout Boston. Services include street outreach, shelter-based clinics, hospital-based primary care and behavioral health clinics, oral health care, and 104 medical respite beds to provide medical care to people who do not meet criteria for inpatient admission but are not well enough to stay in shelters or on the streets. The program was established in 1985, and its mission is to provide or ensure access to the highest-quality health care for people and families experiencing episodes of homelessness in greater Boston. The program does not ask for official proof of homelessness but cares for anyone referred to it or presenting as homeless at its clinical settings. Continuity of care is seen as critical to high-quality care in this sometimes hard-to-reach population, and the program often continues to follow individuals after they obtain housing.

We gathered longitudinal claims and enrollment data from the Massachusetts Medicaid program on people who were enrolled in the BHCHP from 2013 through 2015. During these years these people were also enrolled in the Primary Care Payment Reform Initiative. This initiative provided primary care practices with a risk-adjusted capitated payment with shared savings, quality incentives, and the possibility of shared risk—similar to other alternative payment models. Primary care clinicians were encouraged to coordinate care, assume accountability for total spending, and integrate behavioral health and primary care.18

We received Massachusetts Medicaid data on 3,907 adults younger than age sixty-five who were attributed to the BHCHP. People ages sixty-four and younger who were US citizens and who had resided in the US for at least five years were eligible for the Primary Care Payment Reform Initiative. We excluded 151 people who had no enrollment information in the data and excluded 3,354 people who were not continuously enrolled for all thirty-six months of the study period. This resulted in a sample of 402 people who were continuously enrolled in the BCHCP from 2013 through 2015. The longitudinal analysis, in contrast to cross-sectional analysis, has the potential to offer valuable insights to organizations that bear financial risk for attributed vulnerable populations in the ACO context, where contracts typically are for multiple years. Examining continuously enrolled people may render findings less generalizable to the entire homeless population, which is known to experience instability in many aspects of life.19 Thus, in sensitivity analyses we compared the demographic characteristics of the people continuously enrolled in the BHCHP to those of people not continuously enrolled in it. We also compared the average spending of those who were continuously enrolled to that of people not continuously enrolled.

We compared people in the BHCHP to 18,638 people who were continuously enrolled in Massachusetts Medicaid and had no evidence of experiencing homelessness in their health care records. In the study period, these people were continuously enrolled in the Boston Medical Center HealthNet Plan, a large safety-net provider health plan that is a Medicaid plan for Massachusetts residents. Each person in this comparison group had at least one claim from the Primary Care Payment Reform Initiative during this period. We excluded people who experienced homelessness, as defined by having a claim during this period with an International Classification of Diseases, Ninth Revision (ICD-9), code for homelessness.

DATA AND VARIABLES

We gathered information on the demographic and socioeconomic characteristics of the BHCHP population from claims data and BHCHP records. These characteristics included age, sex, race/ethnicity, primary language, disability status, monthly income, and veteran status. We also collected from BHCHP medical records the last known housing status of each person—including street, shelter, doubling up (that is, sharing the housing of another person as a result of loss of housing or economic hardship), transitional housing, supportive housing, and housing without support services. In our Massachusetts Medicaid comparison population, data were available on only age, sex, race/ethnicity, primary language, and disability status.

For both the BHCHP and comparison populations, we calculated a risk score for each person in each year using the Verisk Health Diagnostic Cost Group risk-score model, frequently used by insurers to risk-adjust capitated payments.20 The risk score was calculated using age, sex, and ICD-9 or International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10), codes, and it reflects expected spending based on demographic characteristics and total disease burden. In addition, we identified and compared the most prevalent clinical diagnoses in the two populations.

We aggregated health care spending and use in the claims data to the person-year level. Spending in both populations reflected established payment rates in the Massachusetts Medicaid program and included patient cost sharing, although for the vast majority of services, cost sharing was zero. We examined total medical spending as well as spending by type of service defined using the Berenson-Eggers Type of Service codes, which include clinical categories (as opposed to statistical or financial categories) that are relatively stable over time and constant across all payers who use CurrentProcedural Terminology (CPT) codes for billing.21 Within evaluation and management services, we studied office, hospital outpatient, emergency department, home, nursing home, psychiatry, and other specialist or consult visits. We also examined the remaining Berenson-Eggers Type of Service categories: procedures, imaging, tests, durable medical equipment, other, and exceptions or unclassified. In addition, we analyzed spending for and use of inpatient care and prescription drugs. Of note, we did not have access to substance use disorder claims from Massachusetts Medicaid because of common nationwide legal restrictions.22 Specifically, claims were excluded if a substance use disorder diagnosis was coded as the primary diagnosis. However, claims in which substance use disorder diagnoses were not primary diagnoses were retained, but the substance use disorder diagnosis codes were omitted to maintain confidentiality. This applied to both the BHCHP and comparison populations.

STATISTICAL ANALYSIS

In unadjusted analyses we compared average per person total medical spending and spending by outpatient, inpatient, and prescription drug categories between the BHCHP and Massachusetts Medicaid populations by year. We then compared average annual levels of per person spending and use between these groups for each category of service, using two-tailed t-tests.

In adjusted analyses we compared spending and use between these two groups in the aggregate and by category of service, adjusted for age, sex, race/ethnicity, primary language, disability status, and Verisk Health Diagnostic Cost Group risk score. Since homeless people have a substantially larger disease burden than most comparison populations do, and unstable housing can be correlated with disease burden, we also analyzed adjusted differences in spending and use without adjusting for the risk score. This helped capture to what extent the differences in spending and use were sensitive to adjustment for the risk score.

Multiple inference adjustment was conducted using the Westfall and Young method, which produced p values that accounted for the family-wise error rate.23 All spending was inflation adjusted to 2015 US dollars. Analyses were performed using Stata, version 15.

This study was approved by the Harvard Medical School Institutional Review Board.

LIMITATIONS

Our study had several limitations. First, our BHCHP population was continuously enrolled for three years (2013–15) and part of the Primary Care Payment Reform Initiative. Furthermore, housing status may have varied for these patients over the study period, and the last captured housing status was the only status available. Overall, more than 60 percent of our sample had some form of housing during the study period. These attributes might have rendered these people less representative of the broader homeless population.24

Second, differences in risk scores may reflect differences not only in true disease burden but also in coding intensity (the extent to which providers code relevant diagnoses from a clinical encounter).25

Third, Massachusetts Medicaid behavioral health claims, including psychiatry claims, for the BHCHP population were provided by the Massachusetts Behavioral Health Partnership starting with claims for September 2013. Thus, comparisons of spending and use for psychiatry services relied on 2014 and 2015 data only.

Finally, the analysis was limited to claims in which substance use was not the primary diagnosis.22 BHCHP estimates indicate that approximately 18 percent of total health care spending for BHCHP enrollees is attributable to substance use disorder treatment. To the extent that average per person spending for the BHCHP population in our study may appear slightly lower than that in previous studies, this may be because our results represent a conservative estimate of that population’s higher spending and use.

STUDY RESULTS

DEMOGRAPHICS

Of the 402 BHCHP patients continuously enrolled for three years, the mean age was 52.3 years, and 72.4 percent were male (exhibit 1). In addition, 39.1 percent were white, 36.8 percent were black, and 10.9 percent were Hispanic. The average risk score was 6.5. Most members of this population (98.3 percent) had English as their primary language, 22.4 percent had a disability, and 13.0 percent were veterans. Mean montly income was $519. In terms of housing status, 5.2 percent were on the street, 16.9 percent stayed in a shelter, 10.5 percent were doubled up, 3.7 percent lived in transitional housing, 25.1 percent lived in supportive housing, and 34.1 percent lived in housing with no support services. In comparison, the Massachusetts Medicaid population had an average age of 43.5 years and was 33.6 percent male, 60.5 percent white, 11.7 percent black, and 18.2 percent Hispanic. That population’s average risk score was 3.2, 80.4 percent reported that English was their primary language, and 24.6 percent had a disability.

DISEASE BURDEN

Disorders of the joint and respiratory symptoms were two of the leading categories of diagnoses for both groups (exhibit 2). Other leading categories for both groups included disorders of soft tissues, essential hypertension, and disorders of the back. However, the BHCHP population notably had a higher prevalence of viral hepatitis (37.3 percent) than the general Medicaid population (not shown).

Exhibit 2.

Most Common Clinical Diagnoses

Boston Health Care for the Homeless Program Population (N = 402) Massachusetts Medicaid Population (N = 18,638)
Diagnosis Code Percent Diagnosis Code Percent
Other and unspecified disorders of joint 62.2 Respiratory system symptoms and other chest symptoms 51.4
Other disorders of soft tissues 59.2 General symptoms 50.0
Respiratory system symptoms and other chest symptoms 59.2 Other and unspecified disorders of joint 47.4
General symptoms 58.5 Other and unspecified disorders of back 43.0
Essential hypertension 53.0 Other disorders of soft tissues 41.3
Episodic mood disorders 46.8 Anxiety, dissociative and somatoform disorders 39.9
Other and unspecified disorders of back 46.5 Disorders of lipoid metabolism 37.9
Anxiety, dissociative and somatoform disorders 42.5 Other symptoms involving abdomen and pelvis 37.8
Symptoms involving digestive system 40.3 Essential hypertension 35.9
Other symptoms involving abdomen and pelvis 39.3 Nondependent abuse of drugs 32.1
Symptoms involving head and neck 38.3 Symptoms involving head and neck 30.3
Viral hepatitis 37.3 Symptoms involving skin and other integumentary tissue 29.6
Disorders of refraction and accommodation 37.3 Symptoms involving digestive system 29.6
Symptoms involving skin and other integumentary tissue 37.1 Depressive disorder, not elsewhere classified 27.5
Major depressive disorder, single episode, unspecified 35.6 Episodic mood disorders 27.3
Injury other and unspecified 35.6 Overweight, obesity, and other hyperalimentation 26.8
Nonspecific findings on examination of blood 33.6 Diseases of esophagus 25.3
Diseases of esophagus 31.3 Disorders of refraction and accommodation 24.0
Adjustment reaction 31.1 Symptoms involving urinary system 22.3
Diabetes mellitus 29.9 Nonspecific findings on examination of blood 21.4

Source:Authors’ analysis of 2013–2015 data from the Boston Health Care for the Homeless Program and Massachusetts Medicaid program.

Notes:This table shows the prevalence of diagnoses as indicated by the ICD-9 codes in both populations.

The prevalence of mental health comorbidities was greater in the BHCHP population (exhibit 2). Episodic mood disorders (46.8 percent); anxiety, dissociative, or somatoform disorders (42.5 percent); and major depressive disorder (35.6 percent) were all among the top twenty diagnoses in BHCHP patients and more prevalent among that population than among the Massachusetts Medicaid population.

UNADJUSTED SPENDING TRENDS

In the BHCHP population, total health care spending per person averaged $15,256 in 2013, which was roughly 2.2 times more than the $7,013 per person in the Massachusetts Medicaid population (exhibit 3). In 2015 total spending per person had grown to $21,598 in the BHCHP population, a 42 percent increase from 2013. This amount was about 2.7 times greater than the total spending of $8,080 per person in the Massachusetts Medicaid population in 2015 (a 15 percent increase from 2013). In a sensitivity analysis that omitted behavioral health claims from the Massachusetts Behavioral Health Partnership from each year, the comparison was similar (see online appendix A).26 Since Massachusetts Behavioral Health Partnership claims were available for 2014–15 only, we conducted this sensitivity analysis to ensure that the increase was not explained by the absence of behavioral health claims in 2013.

Exhibit 3.

Average annual health care spending per person continuously enrolled in the Boston Health Care for the Homeless Program (BHCHP) or Massachusetts Medicaid in 2013–15, by type of spending

Population Year Inpatient Outpatient Prescription Drugs
BHCHP 2013 2339 9947 2970
MH 2013 1198 3977 1838
BHCHP 2014 3359 10803 5551
MH 2014 1242 3975 2371
BHCHP 2015 3590 11444 6564
MH 2015 1480 3993 2607
graphic file with name nihms-1608999-t0001.jpg

This increase in BHCHP spending was driven most by growth in prescription drug spending, which rose from $2,970 per person in 2013 to $6,564 per person in 2015—an increase of 121 percent (exhibit 3). There was a more modest 42 percent increase from $1,838 per person in 2013 to $2,607 per person in 2015 among the Massachusetts Medicaid population. In 2015 BHCHP prescription drug spending was roughly 2.5 times greater than that in the Massachusetts Medicaid population, up from about 1.6 times greater in 2013. This is partly explained by the increase in spending on hepatitis C treatments—such as ledipasvir-sofosbuvir (Harvoni), which Massachusetts Medicaid began to cover in December 2013—consistent with the fact that the BHCHP population had a higher prevalence of viral hepatitis than the Massachusetts Medicaid group did. Overall, the BHCHP population incurred no spending on ledipasvir-sofosbuvir in 2013 but $2,700 per person in 2015, totaling $1.1 million in this sample. In contrast, Massachusetts Medicaid spent nothing on ledipasvir-sofosbuvir in 2013, but $300 per person in 2015, amounting to $5.5 million in this sample (data not shown).

Outpatient spending in the BHCHP population grew 15 percent from $9,947 per person in 2013 to $11,444 per person in 2015, and inpatient spending increased 53 percent from $2,339 per person in 2013 to $3,590 per person in 2015 (exhibit 3). By comparison, outpatient spending in the Massachusetts Medicaid population grew less than 1 percent from $3,977 per person in 2013 to $3,993 per person in 2015, and inpatient spending increased 24 percent from $1,198 per person in 2013 to $1,480 per person in 2015. Outpatient and inpatient spending among the BHCHP cohort were roughly 2.9 and 2.4 times greater, respectively, than those in the Massachusetts Medicaid comparison population in 2015.

SPENDING BY CATEGORY

On average across the three years, people in the BHCHP population incurred unadjusted spending of $18,764 per person per year—roughly 2.5 times more than the per person per year of spending of $7,561 in the comparison Massachusetts Medicaid population (exhibit 4). When we adjusted for age, sex, race/ethnicity, language, and disability status, this amounted to a difference of $9,825 per person per year. When we additionally controlled for the risk score, this difference was $4,387.

Exhibit 4.

Average Health Care Spending and Utilization by Category of Service

BHCHP Population (N=402) Medicaid Population (N= 18,638) Ratio of BHCHP to Medicaid Adjusted Difference
With Risk Score Without Risk Score
Spending ($ average per person per year)
Total (Inpatient, Outpatient, and Drug) 18763.5 7560.73 2.48 4386.96*** 9825.28****
 Inpatient 3105.89 1306.68 2.38 −1035.45* 1362.14
 Outpatienta 10568.34 3981.87 2.65 4064.23**** 6227.11****
  Evaluation and Management
   Office Visits 773.64 820.36 0.94 −377.97**** −172.36
   Hospital Outpatient Visits 250.98 107.65 2.33 −91.53** 98.7
   Emergency 436.63 278.59 1.57 72.13 190.84
   Home Visits 2223.52 1.20 1859.48 2138.67**** 2252.69***
   Nursing Home Visits 3.67 2.29 1.60 −5.57 −0.54
   Psychiatryb 87.27 245.62 0.36 −89.51**** −65.26***
   Other Specialists/Consults 94.07 73.63 1.28 −25.33 −9.82
  Procedures 456.96 705.43 0.65 −836.26**** −357.35***
  Imaging 445.56 611.76 0.73 −502.42**** −279.90***
  Tests 283.28 420.17 0.67 −317.85**** −179.36****
  Durable Medical Equipment 101.14 74.18 1.36 −53.19 6.41
  Other 422.02 179.48 2.35 −23.86 189.58
  Exceptions/Unclassified 5000.04 462.59 10.81 4185.43**** 4562.26****
 Prescription Drug 5089.27 2272.18 2.24 1358.18 2236.03*
Utilization (volume per person per year)
 Inpatient Admissions 0.34 0.14 2.32 −0.04 0.17*
 Outpatienta
  Evaluation and Management
   Office Visits 7.88 8.43 0.93 −2.83*** −0.96
   Hospital Outpatient Visits 2.90 0.83 3.50 0.10 1.79**
   Emergency 4.65 1.76 2.64 2.59*** 3.31***
   Home Visits 4.34 0.01 387.35 4.16**** 4.39***
   Nursing Home Visits 0.04 0.03 1.29 −0.09* −0.02
   Psychiatryb 1.45 3.58 0.40 −1.13*** −0.79**
   Other Specialists/Consults 1.24 1.09 1.14 −0.19 −0.05
  Procedures 5.33 4.80 1.11 −2.30*** 0.05
  Imaging 8.36 4.81 1.74 1.73* 3.72**
  Tests 21.13 16.61 1.27 −0.97 4.91
  Durable Medical Equipment 1.26 1.03 1.22 −0.68* −0.04
Prescription Drug Scripts 63.09 34.75 1.82 16.54*** 24.06***

Source:Authors’ analysis of 2013–2015 data from BHCHP and from the Massachusetts Medicaid program.

Notes:This table compares average spending and utilization per person per year among individuals who were continuously enrolled from 2013 through 2015 in the Boston Health Care for the Homeless Program to individuals continuously enrolled in the Massachusetts Medicaid program. Spending is reported in 2015 U.S. dollars.

*

p<.1,

**

p<.05,

***

p<.01,

****

p<.001 using P values that accounted for the family-wise error rate (multiple inference adjustment). Standard P values that were not adjusted for multiple inference, which signaled a higher degree of statistical significance, are not shown.

a

Outpatient services are largely organized by BETOS classification, which is the Berenson-Eggers Type of Service classification. The Other category includes ambulance, chiropractic, enteral and parenteral, chemotherapy, other drugs, vision, hearing and speech services, and influenza immunization. The Exceptions/Unclassified category includes other services in the Medicare and non-Medicare fee schedules, local codes, and undefined codes. Utilization for the “Other” and the “Exceptions/Unclassified” categories were omitted because these categories had different types of care that could not be counted using a common unit.

b

Behavioral Health Services, defined as psychiatry visits per the BETOS classification system, were compared in 2014 and 2015 only, given that Massachusetts Behavioral Health Partnership claims data were available starting in September 2013.

Compared to the Massachusetts Medicaid population, the BHCHP population incurred about 2.2 times more unadjusted spending on prescription drugs ($5,089 versus $2,272). The adjusted difference was $2,236 without and $1,358 with the risk score controlled for. The BHCHP population incurred 2.4 times more unadjusted spending of on inpatient care ($3,106 versus $1,307)—an adjusted difference of $1,362 without controlling for the risk score. When we additionally adjusted for risk, the difference was −$1,035. The BHCHP population incurred 2.7 times more unadjusted spending on outpatient care ($10,568 versus $3,982). The adjusted difference was $6,227 without and $4,064 with the risk score controlled for.

Within outpatient care, the BHCHP population incurred more unadjusted spending on emergency department visits ($437 versus $279 per person per year). The adjusted difference was $191 without and $72 with the risk controlled for. The BHCHP population, which often transitions through supportive housing with clinician home visits, incurred more spending on home visits, a defined subcategory of the Berenson-Eggers Type of Service classification system ($2,224 versus $1 per person per year), with adjusted differences that were similar and statistically significant.

Spending on evaluation and management for psychiatry was lower in the BHCHP population than in the Massachusetts Medicaid comparison group (unadjusted $87 versus $246, with adjusted differences of −$65 without risk controlled for and −$90 with risk controlled for). Spending for the two groups was not significantly different for other specialist or consult visits ($94 versus $74, with adjusted differences of −$10 and −$25). The BHCHP population incurred less spending than the comparison group on procedures ($457 versus $705, with adjusted differences of −$357 and −$836), imaging ($446 versus $612, with adjusted differences of −$280 and −$502), and tests ($283 versus $420, with adjusted differences of −$179 and −$318).

USE BY CATEGORY

In unadjusted terms, the BHCHP population used more of every category of service except psychiatry evaluation and management visits (1.45 versus 3.58 visits per person per year, with adjusted differences of −0.79 without controlling for risk and −1.13 controlling for risk) and office visits (7.88 versus 8.43, with adjusted differences of −0.96 and −2.83).

Notably, people in the BHCHP population visited emergency departments an unadjusted 4.65 times per person per year, compared to 1.76 visits in the comparison population (adjusted differences of 3.31 and 2.59). On average, people in the BHCHP population were admitted to the hospital an unadjusted 0.34 times per year, compared to 0.14 in the comparison group, with adjusted differences of 0.17 (p=0.08) and −0.04 (p=0.67) (exhibit 4).

DISCUSSION

This cohort study provides novel evidence of substantial differences in health care spending and use among a population whose members experienced episodes of homelessness and were attributed to a precursor ACO, compared to a similar Medicaid population without unstable housing. Average annual unadjusted total spending for people who experienced episodes of homelessness was 2.5 times greater than that among the comparison population. Unadjusted spending was 2.4 times greater for inpatient spending, 2.7 times greater for outpatient spending, and 2.2 times greater for prescription drug spending. Furthermore, health care spending in the BHCHP population was roughly 3.3 times greater than the average national Medicaid spending per enrollee of $5,736 in 2014.27

Adjusted differences in spending between the BHCHP and comparison cohorts were consistent in direction with the unadjusted differences among most segments of spending, but the magnitudes of the adjusted differences were sensitive to adjustment for the risk score. When risk was controlled for, the extent to which the BHCHP population incurred more spending than the comparison Medicaid population was generally attenuated. This suggests that the risk score is meaningfully correlated with unstable housing and that adjusting for risk partially explains away the differences in spending that are otherwise likely attributable to unstable housing.

Differences in adjusted spending between the BHCHP and comparison cohorts were driven by differences in outpatient rather than inpatient spending. One striking difference in outpatient spending between the two groups was home visits. A core function of the BHCHP is to provide home visits for patients after they transition into housing. This includes addressing patients’ medical, behavioral health, and case management needs in a home setting rather than a clinic setting. These home visits are billable as Medicaid evaluation and management visits. Thus, home visits likely help explain why outpatient spending in the BHCHP group exceeded spending in a similar control group that did not experience housing instability, as opposed to office visits, which incurred less spending in the BHCHP group. Of note, the BHCHP cohort also had significantly more emergency department visits. However, the difference in spending on these visits was not significant after adjustment, in part because of higher variance around the mean in emergency department spending. The same was true for prescription drug spending. The BHCHP cohort also received more imaging (though spending less on it)—likely as a result of differences in the types of imaging received.

Our study helps address a major challenge in studying health care for unstably housed populations: the unstable enrollment of homeless people in any insurance program. People experiencing homelessness often lose health insurance because of frequent address changes that prevent them from receiving eligibility redetermination paperwork, inability to work or pay premiums, and other life challenges that make it difficult to meet the requirements for maintaining coverage.5,24 At the same time, studying people who were continuously enrolled in the BHCHP and who had episodes of homelessness may have rendered our results less generalizable to the broader homeless population. Indeed, continuously enrolled people differed on sociodemographic dimensions from people not continuously enrolled (appendix B).26 However, our comparison at the monthly level of people in the program who were and were not continuously enrolled in terms of spending demonstrated broadly similar patterns (appendix C).26

To our knowledge, this is the first study to provide a detailed analysis of health care spending and use based on longitudinal claims data in a continuously enrolled population whose members experienced episodes of homelessness, compared to a general population of Medicaid enrollees with no evidence of experiencing homelessness. Our unadjusted results were consistent with previous studies’ findings of high rates of inpatient, outpatient, and emergency department visits among the homeless population,517 though most previous studies did not have the granularity to look at the other types of services (such as specialty visits, procedures, imaging, and tests) that we examined. The association between homelessness and intensive health care use is thought to be due both to the high burden of co-occurring medical, psychiatric, and substance use disorders and to social factors such as challenges with health literacy, difficulty adhering to medication regimens, lack of transportation, lack of child care, perceived discrimination in health care settings, and cognitive impairment.15,28 Our study built on two prior studies that also used claims data for BHCHP patients. The first showed that emergency department use among homeless people remained high even after the expansion of health insurance in Massachusetts, which included both a Medicaid expansion in the early 1990s and a larger insurance expansion involving subsidized private plans in 2006.5 The other showed that homeless people had greater spending and use relative to the Medicaid population, though it used only one year of data.8

Notably, our study found fewer psychiatric office visits in the BHCHP population than in the comparison group. Though comparisons of psychiatric service use in homeless and nonhomeless populations are few, our results are broadly consistent with a prior study suggesting that homeless patients used fewer outpatient services than a nonhomeless population did.7 Possible explanations include reluctance to establish longitudinal relationships with providers because of extensive trauma histories, difficulty engaging with traditional clinic models that rely on patients to show up for regular appointments despite many other survival demands,24 or an inadequate supply of psychiatric prescribers for the homeless population.

These findings from a precursor to the Massachusetts Medicaid ACO program may help improve the design of alternative payment models for vulnerable populations. ACO contracts and alternative payment models have two key economic parameters over which payers and providers typically negotiate: the size of the budget (or spending target) and its growth rate. Our results show that total Medicaid spending for people experiencing episodes of homelessness can average over $4,300 per person per year more than spending for Medicaid enrollees with no evidence of experiencing homelessness—even after risk is adjusted for. Thus, budgets for provider organizations that care for similar unstably housed populations may need to be further adjusted to allow the organizations to care for such populations in a sustainable manner. Using risk adjustment for social determinants of health is one possible way to account for the unique needs of populations with unstable housing. Massachusetts Medicaid began adjusting capitation rates for homelessness based on a 2016 analysis that estimated the incremental costs of caring for people with housing instability to be approximately $550 per person per year.29,30 In light of the spending differences found in our analysis between people who did and did not experience housing instability ($4,387 per person per year when adjusted for all covariates), this $550 base adjustment reflects only about one-eighth of the spending difference we observed.

In conclusion, these novel data improve understanding of health care spending and use among people with unstable housing and thus may inform the design of Medicaid alternative payment models in the era of accountable care.

Supplementary Material

Appendix Exhibits

Exhibit 1.

Characteristics of the Study Population

Characteristic Boston Health Care for the Homeless Program Population (N = 402) Massachusetts Medicaid Population (N = 18,638)
Age (yr) 52.3 ± 7.3 43.5 ± 10.4
Male (%) 72.4 33.6
Female (%) 27.6 66.4
Risk Score 6.5 ± 8.7 3.2 ± 3.9
Race (%)
 White 39.1 60.5
 Black 36.8 11.7
 Hispanic 10.9 18.2
 Asian 0.0 3.9
 Other 3.0 0.8
 Unknown 10.2 4.9
Primary Language (%)
 English 98.3 80.4
 Spanish 1.7 8.1
 Other or unknown 0.0 11.5
Disability (%) 22.4 24.6
Income ($/month) --
 Mean 519 ± 569
 25th percentile 0
 50th percentile 700
 75th percentile 750
Housing Status (%) --
 Street 5.2
 Shelter 16.9
 Doubling Up 10.5
 Transitional Housing 3.7
 Supportive Housing 25.1
 Housing without support services 34.1
 Unknown 4.5
Veteran Status (%) 13.0 --

Source:Authors’ analysis of 2013–2015 data from the Boston Health Care for the Homeless Program and Massachusetts Medicaid program.

Notes:The Boston Health Care for the Homeless Program population comprised homeless and housing unstable patients affiliated with the program. The Massachusetts Medicaid population comprised general Medicaid enrollees in Massachusetts; individuals with the ICD-9 diagnosis code for homelessness were removed from the sample. This table provides characteristics of the continuously enrolled individuals among these populations. Enrollee characteristics in the general Massachusetts Medicaid population did not include income, housing status, or veteran status. The risk score was calculated using the Verisk Health Diagnostic Cost Group (DxCG) model, which used age, sex, and diagnoses. The ± denotes standard deviations

ACKNOWLEDGMENTS

This work was supported by a grant from the Office of the Director of the National Institutes of Health (NIH Director’s Early Independence Award No. DP5-OD024564 to Zirui Song). The funder had no role in the design or conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. The authors gratefully acknowledge Andrew Hicks for the calculation of risk scores using the Verisk Health Diagnostic Cost Group risk-adjustment model and Rob Hass for assistance with the data.

ENDNOTES

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Appendix Exhibits

RESOURCES